{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:45:38Z","timestamp":1783572338565,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"St. Baldrick\u2019s Foundation\/American Association for Cancer Research\/Stand Up to Cancer Pediatric Dream Team","award":["SU2C-AACR-DT-27-17"],"award-info":[{"award-number":["SU2C-AACR-DT-27-17"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-153092"],"award-info":[{"award-number":["PJT-153092"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH Prostate Cancer","award":["1016339"],"award-info":[{"award-number":["1016339"]}]},{"name":"NIH Prostate Cancer","award":["223493"],"award-info":[{"award-number":["223493"]}]},{"name":"NIH Prostate Cancer","award":["5P50 CA097186-17"],"award-info":[{"award-number":["5P50 CA097186-17"]}]},{"DOI":"10.13039\/501100009708","name":"The Novo Nordisk Foundation","doi-asserted-by":"crossref","award":["NNF19OC0058387"],"award-info":[{"award-number":["NNF19OC0058387"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000109","name":"Prostate Cancer Canada","doi-asserted-by":"publisher","award":["RS2014-02"],"award-info":[{"award-number":["RS2014-02"]}],"id":[{"id":"10.13039\/501100000109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"MITACS","doi-asserted-by":"crossref","award":["IT06057"],"award-info":[{"award-number":["IT06057"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Proteoglycans are proteins that are modified with glycosaminoglycan chains. Chondroitin sulfate proteoglycans (CSPGs) are currently being exploited as targets for drug-delivery in various cancer indications, however basic knowledge on how CSPGs are internalized in tumor cells is lacking. In this study we took advantage of a recombinant CSPG-binding lectin VAR2CSA (rVAR2) to track internalization and cell fate of CSPGs in tumor cells. We found that rVAR2 is internalized into cancer cells via multiple internalization mechanisms after initial docking on cell surface CSPGs. Regardless of the internalization pathway used, CSPG-bound rVAR2 was trafficked to the early endosomes in an energy-dependent manner but not further transported to the lysosomal compartment. Instead, internalized CSPG-bound rVAR2 proteins were secreted with exosomes to the extracellular environment in a strictly chondroitin sulfate-dependent manner. In summary, our work describes the cell fate of rVAR2 proteins in tumor cells after initial binding to CSPGs, which can be further used to inform development of rVAR2-drug conjugates and other therapeutics targeting CSPGs.<\/jats:p>","DOI":"10.1038\/s41598-022-07025-6","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T06:05:25Z","timestamp":1645596325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells"],"prefix":"10.1038","volume":"12","author":[{"given":"Chris Kedong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Nelepcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Htoo Zarni","family":"Oo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakir","family":"Tahiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh","family":"Esfandnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Ghaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Adomat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dagil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Gustavsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Salanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul H.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Al Nakouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Daugaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"7025_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s10354-016-0432-7","volume":"166","author":"SR Elkin","year":"2016","unstructured":"Elkin, S. R., Lakoduk, A. M. & Schmid, S. L. Endocytic pathways and endosomal trafficking: A primer. Wien Med. Wochenschr. 166, 196\u2013204. https:\/\/doi.org\/10.1007\/s10354-016-0432-7 (2016).","journal-title":"Wien Med. Wochenschr."},{"key":"7025_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrm.2017.132","volume":"19","author":"M Kaksonen","year":"2018","unstructured":"Kaksonen, M. & Roux, A. Mechanisms of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 19, 313\u2013326. https:\/\/doi.org\/10.1038\/nrm.2017.132 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"7025_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.14670\/HH-25.99","volume":"25","author":"M Jovic","year":"2010","unstructured":"Jovic, M., Sharma, M., Rahajeng, J. & Caplan, S. The early endosome: A busy sorting station for proteins at the crossroads. Histol. Histopathol. 25, 99\u2013112. https:\/\/doi.org\/10.14670\/HH-25.99 (2010).","journal-title":"Histol. Histopathol."},{"key":"7025_CR4","doi-asserted-by":"publisher","first-page":"011503","DOI":"10.1063\/1.5087122","volume":"3","author":"X Li","year":"2019","unstructured":"Li, X. et al. Challenges and opportunities in exosome research\u2014Perspectives from biology, engineering, and cancer therapy. APL Bioeng. 3, 011503. https:\/\/doi.org\/10.1063\/1.5087122 (2019).","journal-title":"APL Bioeng."},{"key":"7025_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41580-018-0053-7","volume":"19","author":"PJ Cullen","year":"2018","unstructured":"Cullen, P. J. & Steinberg, F. To degrade or not to degrade: Mechanisms and significance of endocytic recycling. Nat. Rev. Mol. Cell Biol. 19, 679\u2013696. https:\/\/doi.org\/10.1038\/s41580-018-0053-7 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"7025_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41556-018-0244-7","volume":"21","author":"RE Lawrence","year":"2019","unstructured":"Lawrence, R. E. & Zoncu, R. The lysosome as a cellular centre for signalling, metabolism and quality control. Nat. Cell Biol. 21, 133\u2013142. https:\/\/doi.org\/10.1038\/s41556-018-0244-7 (2019).","journal-title":"Nat. Cell Biol."},{"key":"7025_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4161\/mabs.22854","volume":"5","author":"M Ritchie","year":"2013","unstructured":"Ritchie, M., Tchistiakova, L. & Scott, N. Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates. MAbs 5, 13\u201321. https:\/\/doi.org\/10.4161\/mabs.22854 (2013).","journal-title":"MAbs"},{"key":"7025_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1541-7786.MCR-19-0582","volume":"18","author":"P Khongorzul","year":"2020","unstructured":"Khongorzul, P., Ling, C. J., Khan, F. U., Ihsan, A. U. & Zhang, J. Antibody-drug conjugates: A comprehensive review. Mol. Cancer Res. 18, 3\u201319. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0582 (2020).","journal-title":"Mol. Cancer Res."},{"key":"7025_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13046-017-0667-1","volume":"37","author":"C Chalouni","year":"2018","unstructured":"Chalouni, C. & Doll, S. Fate of antibody-drug conjugates in cancer cells. J. Exp. Clin. Cancer Res. 37, 20. https:\/\/doi.org\/10.1186\/s13046-017-0667-1 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"7025_CR10","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.2147\/DDDT.S135571","volume":"11","author":"M Kalim","year":"2017","unstructured":"Kalim, M. et al. Intracellular trafficking of new anticancer therapeutics: Antibody-drug conjugates. Drug Des. Dev. Ther. 11, 2265\u20132276. https:\/\/doi.org\/10.2147\/DDDT.S135571 (2017).","journal-title":"Drug Des. Dev. Ther."},{"key":"7025_CR11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ccell.2015.09.003","volume":"28","author":"A Salanti","year":"2015","unstructured":"Salanti, A. et al. Targeting human cancer by a glycosaminoglycan binding malaria protein. Cancer Cell 28, 500\u2013514. https:\/\/doi.org\/10.1016\/j.ccell.2015.09.003 (2015).","journal-title":"Cancer Cell"},{"key":"7025_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2017.03.021","volume":"72","author":"R Seiler","year":"2017","unstructured":"Seiler, R. et al. An oncofetal glycosaminoglycan modification provides therapeutic access to cisplatin-resistant bladder cancer. Eur. Urol. 72, 142\u2013150. https:\/\/doi.org\/10.1016\/j.eururo.2017.03.021 (2017).","journal-title":"Eur. Urol."},{"key":"7025_CR13","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/s41467-018-05793-2","volume":"9","author":"MO Agerbaek","year":"2018","unstructured":"Agerbaek, M. O. et al. The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner. Nat. Commun. 9, 3279. https:\/\/doi.org\/10.1038\/s41467-018-05793-2 (2018).","journal-title":"Nat. Commun."},{"key":"7025_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.exppara.2005.12.003","volume":"113","author":"M Fried","year":"2006","unstructured":"Fried, M., Domingo, G. J., Gowda, C. D., Mutabingwa, T. K. & Duffy, P. E. Plasmodium falciparum: Chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta. Exp. Parasitol. 113, 36\u201342. https:\/\/doi.org\/10.1016\/j.exppara.2005.12.003 (2006).","journal-title":"Exp. Parasitol."},{"key":"7025_CR15","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1128\/IAI.67.12.6596-6602.1999","volume":"67","author":"J Gysin","year":"1999","unstructured":"Gysin, J., Pouvelle, B., Fievet, N., Scherf, A. & Lepolard, C. Ex vivo desequestration of Plasmodium falciparum-infected erythrocytes from human placenta by chondroitin sulfate A. Infect. Immun. 67, 6596\u20136602. https:\/\/doi.org\/10.1128\/IAI.67.12.6596-6602.1999 (1999).","journal-title":"Infect. Immun."},{"key":"7025_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/s0166-6851(97)00082-0","volume":"88","author":"J Gysin","year":"1997","unstructured":"Gysin, J., Pouvelle, B., Le Tonqueze, M., Edelman, L. & Boffa, M. C. Chondroitin sulfate of thrombomodulin is an adhesion receptor for Plasmodium falciparum-infected erythrocytes. Mol. Biochem. Parasitol. 88, 267\u2013271. https:\/\/doi.org\/10.1016\/s0166-6851(97)00082-0 (1997).","journal-title":"Mol. Biochem. Parasitol."},{"key":"7025_CR17","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.autrev.2011.05.019","volume":"10","author":"S Haylock-Jacobs","year":"2011","unstructured":"Haylock-Jacobs, S., Keough, M. B., Lau, L. & Yong, V. W. Chondroitin sulphate proteoglycans: Extracellular matrix proteins that regulate immunity of the central nervous system. Autoimmun. Rev. 10, 766\u2013772. https:\/\/doi.org\/10.1016\/j.autrev.2011.05.019 (2011).","journal-title":"Autoimmun. Rev."},{"key":"7025_CR18","doi-asserted-by":"publisher","first-page":"295254","DOI":"10.1155\/2014\/295254","volume":"2014","author":"G Tzanakakis","year":"2014","unstructured":"Tzanakakis, G., Kovalszky, I., Heldin, P. & Nikitovic, D. Proteoglycans\/glycosaminoglycans: From basic research to clinical practice. Biomed. Res. Int. 2014, 295254. https:\/\/doi.org\/10.1155\/2014\/295254 (2014).","journal-title":"Biomed. Res. Int."},{"key":"7025_CR19","doi-asserted-by":"publisher","first-page":"642798","DOI":"10.1155\/2014\/642798","volume":"2014","author":"S Avram","year":"2014","unstructured":"Avram, S., Shaposhnikov, S., Buiu, C. & Mernea, M. Chondroitin sulfate proteoglycans: Structure-function relationship with implication in neural development and brain disorders. Biomed. Res. Int. 2014, 642798. https:\/\/doi.org\/10.1155\/2014\/642798 (2014).","journal-title":"Biomed. Res. Int."},{"key":"7025_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ph11010027","author":"VH Pomin","year":"2018","unstructured":"Pomin, V. H. & Mulloy, B. Glycosaminoglycans and proteoglycans. Pharmaceuticals (Basel) https:\/\/doi.org\/10.3390\/ph11010027 (2018).","journal-title":"Pharmaceuticals (Basel)"},{"key":"7025_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-bioeng-071516-044610","volume":"19","author":"DS da Costa","year":"2017","unstructured":"da Costa, D. S., Reis, R. L. & Pashkuleva, I. Sulfation of glycosaminoglycans and its implications in human health and disorders. Annu. Rev. Biomed. Eng. 19, 1\u201326. https:\/\/doi.org\/10.1146\/annurev-bioeng-071516-044610 (2017).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"7025_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1521654031000072148","volume":"55","author":"KV Venkatachalam","year":"2003","unstructured":"Venkatachalam, K. V. Human 3\u2019-phosphoadenosine 5\u2019-phosphosulfate (PAPS) synthase: Biochemistry, molecular biology and genetic deficiency. IUBMB Life 55, 1\u201311. https:\/\/doi.org\/10.1080\/1521654031000072148 (2003).","journal-title":"IUBMB Life"},{"key":"7025_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0020-711x(80)90003-8","volume":"12","author":"AA Farooqui","year":"1980","unstructured":"Farooqui, A. A. 3\u2019-Phosphoadenosine 5\u2019-phosphosulphate metabolism in mammalian tissues. Int. J. Biochem. 12, 529\u2013536. https:\/\/doi.org\/10.1016\/0020-711x(80)90003-8 (1980).","journal-title":"Int. J. Biochem."},{"key":"7025_CR24","doi-asserted-by":"publisher","first-page":"631274","DOI":"10.3389\/fmicb.2021.631274","volume":"12","author":"I Ripa","year":"2021","unstructured":"Ripa, I., Andreu, S., Lopez-Guerrero, J. A. & Bello-Morales, R. Membrane rafts: Portals for viral entry. Front. Microbiol. 12, 631274. https:\/\/doi.org\/10.3389\/fmicb.2021.631274 (2021).","journal-title":"Front. Microbiol."},{"key":"7025_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1937-6448(10)82003-9","volume":"282","author":"P Lajoie","year":"2010","unstructured":"Lajoie, P. & Nabi, I. R. Lipid rafts, caveolae, and their endocytosis. Int. Rev. Cell Mol. Biol. 282, 135\u2013163. https:\/\/doi.org\/10.1016\/S1937-6448(10)82003-9 (2010).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"7025_CR26","doi-asserted-by":"publisher","first-page":"570108","DOI":"10.3389\/fonc.2020.570108","volume":"10","author":"S Song","year":"2020","unstructured":"Song, S., Zhang, Y., Ding, T., Ji, N. & Zhao, H. The dual role of macropinocytosis in cancers: Promoting growth and inducing methuosis to participate in anticancer therapies as targets. Front. Oncol. 10, 570108. https:\/\/doi.org\/10.3389\/fonc.2020.570108 (2020).","journal-title":"Front. Oncol."},{"key":"7025_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ceb.2004.06.001","volume":"16","author":"A Sorkin","year":"2004","unstructured":"Sorkin, A. Cargo recognition during clathrin-mediated endocytosis: A team effort. Curr. Opin. Cell Biol. 16, 392\u2013399. https:\/\/doi.org\/10.1016\/j.ceb.2004.06.001 (2004).","journal-title":"Curr. Opin. Cell Biol."},{"key":"7025_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/978-1-4614-1222-9_2","volume":"729","author":"AL Kiss","year":"2012","unstructured":"Kiss, A. L. Caveolae and the regulation of endocytosis. Adv. Exp. Med. Biol. 729, 14\u201328. https:\/\/doi.org\/10.1007\/978-1-4614-1222-9_2 (2012).","journal-title":"Adv. Exp. Med. Biol."},{"key":"7025_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/cr.2010.19","volume":"20","author":"S Kumari","year":"2010","unstructured":"Kumari, S., Mg, S. & Mayor, S. Endocytosis unplugged: Multiple ways to enter the cell. Cell Res. 20, 256\u2013275. https:\/\/doi.org\/10.1038\/cr.2010.19 (2010).","journal-title":"Cell Res."},{"key":"7025_CR30","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1111\/j.1600-0854.2007.00650.x","volume":"8","author":"TC Fan","year":"2007","unstructured":"Fan, T. C., Chang, H. T., Chen, I. W., Wang, H. Y. & Chang, M. D. A heparan sulfate-facilitated and raft-dependent macropinocytosis of eosinophil cationic protein. Traffic 8, 1778\u20131795. https:\/\/doi.org\/10.1111\/j.1600-0854.2007.00650.x (2007).","journal-title":"Traffic"},{"key":"7025_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0014-5793(04)00050-x","volume":"559","author":"LH Chamberlain","year":"2004","unstructured":"Chamberlain, L. H. Detergents as tools for the purification and classification of lipid rafts. FEBS Lett. 559, 1\u20135. https:\/\/doi.org\/10.1016\/s0014-5793(04)00050-x (2004).","journal-title":"FEBS Lett."},{"key":"7025_CR32","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.3389\/fimmu.2018.02286","volume":"9","author":"J Canton","year":"2018","unstructured":"Canton, J. Macropinocytosis: New insights into its underappreciated role in innate immune cell surveillance. Front. Immunol. 9, 2286. https:\/\/doi.org\/10.3389\/fimmu.2018.02286 (2018).","journal-title":"Front. Immunol."},{"key":"7025_CR33","doi-asserted-by":"publisher","first-page":"10950","DOI":"10.1128\/JVI.05992-11","volume":"86","author":"JS Rossman","year":"2012","unstructured":"Rossman, J. S., Leser, G. P. & Lamb, R. A. Filamentous influenza virus enters cells via macropinocytosis. J. Virol. 86, 10950\u201310960. https:\/\/doi.org\/10.1128\/JVI.05992-11 (2012).","journal-title":"J. Virol."},{"key":"7025_CR34","doi-asserted-by":"publisher","first-page":"e1005595","DOI":"10.1371\/journal.ppat.1005595","volume":"12","author":"B Hernaez","year":"2016","unstructured":"Hernaez, B., Guerra, M., Salas, M. L. & Andres, G. African swine fever virus undergoes outer envelope disruption, capsid disassembly and inner envelope fusion before core release from multivesicular endosomes. PLoS Pathog. 12, e1005595. https:\/\/doi.org\/10.1371\/journal.ppat.1005595 (2016).","journal-title":"PLoS Pathog."},{"key":"7025_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymeth.2017.05.007","volume":"127","author":"S Kuhn","year":"2017","unstructured":"Kuhn, S., Lopez-Montero, N., Chang, Y. Y., Sartori-Rupp, A. & Enninga, J. Imaging macropinosomes during Shigella infections. Methods 127, 12\u201322. https:\/\/doi.org\/10.1016\/j.ymeth.2017.05.007 (2017).","journal-title":"Methods"},{"key":"7025_CR36","doi-asserted-by":"publisher","first-page":"10300","DOI":"10.1038\/srep10300","volume":"5","author":"I Nakase","year":"2015","unstructured":"Nakase, I., Kobayashi, N. B., Takatani-Nakase, T. & Yoshida, T. Active macropinocytosis induction by stimulation of epidermal growth factor receptor and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes. Sci. Rep. 5, 10300. https:\/\/doi.org\/10.1038\/srep10300 (2015).","journal-title":"Sci. Rep."},{"key":"7025_CR37","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: The catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941\u2013D947. https:\/\/doi.org\/10.1093\/nar\/gky1015 (2019).","journal-title":"Nucleic Acids Res."},{"key":"7025_CR38","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1158\/1541-7786.MCR-16-0103","volume":"14","author":"TM Clausen","year":"2016","unstructured":"Clausen, T. M. et al. Oncofetal chondroitin sulfate glycosaminoglycans are key players in integrin signalling and tumor cell motility. Mol. Cancer Res. 14, 1288\u20131299. https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0103 (2016).","journal-title":"Mol. Cancer Res."},{"key":"7025_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11100593","author":"J Ruiz-de-la-Herran","year":"2019","unstructured":"Ruiz-de-la-Herran, J., Tome-Amat, J., Lazaro-Gorines, R., Gavilanes, J. G. & Lacadena, J. Inclusion of a furin cleavage site enhances antitumor efficacy against colorectal cancer cells of ribotoxin alpha-sarcin- or RNase T1-based immunotoxins. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins11100593 (2019).","journal-title":"Toxins (Basel)."},{"key":"7025_CR40","doi-asserted-by":"publisher","first-page":"12955","DOI":"10.1021\/acsomega.9b01585","volume":"4","author":"KE Knewtson","year":"2019","unstructured":"Knewtson, K. E. et al. Antibody-drug conjugate that exhibits synergistic cytotoxicity with an endosome-disruptive peptide. ACS Omega 4, 12955\u201312968. https:\/\/doi.org\/10.1021\/acsomega.9b01585 (2019).","journal-title":"ACS Omega"},{"key":"7025_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/cr.2015.29","volume":"25","author":"B Roucourt","year":"2015","unstructured":"Roucourt, B., Meeussen, S., Bao, J., Zimmermann, P. & David, G. Heparanase activates the syndecan-syntenin-ALIX exosome pathway. Cell Res. 25, 412\u2013428. https:\/\/doi.org\/10.1038\/cr.2015.29 (2015).","journal-title":"Cell Res."},{"key":"7025_CR42","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/ijms18030538","volume":"18","author":"MH Rashed","year":"2017","unstructured":"Rashed, M. H. et al. Exosomes: From garbage bins to promising therapeutic targets. Int. J. Mol. Sci. 18, 538. https:\/\/doi.org\/10.3390\/ijms18030538 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"7025_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5772\/62975","volume":"5","author":"S Nagarajah","year":"2016","unstructured":"Nagarajah, S. Exosome secretion\u2014More than simple waste disposal? Implications for physiology, diagnostics and therapeutics. J. Circ. Biomark. 5, 7. https:\/\/doi.org\/10.5772\/62975 (2016).","journal-title":"J. Circ. Biomark."},{"key":"7025_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12943-019-1049-4","volume":"18","author":"W Feng","year":"2019","unstructured":"Feng, W., Dean, D. C., Hornicek, F. J., Shi, H. & Duan, Z. Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol. Cancer 18, 124. https:\/\/doi.org\/10.1186\/s12943-019-1049-4 (2019).","journal-title":"Mol. Cancer"},{"key":"7025_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-019-0995-1","volume":"18","author":"Y Guo","year":"2019","unstructured":"Guo, Y. et al. Effects of exosomes on pre-metastatic niche formation in tumors. Mol. Cancer 18, 39. https:\/\/doi.org\/10.1186\/s12943-019-0995-1 (2019).","journal-title":"Mol. Cancer"},{"key":"7025_CR46","doi-asserted-by":"publisher","first-page":"R58","DOI":"10.1186\/bcr2895","volume":"13","author":"CA Cooney","year":"2011","unstructured":"Cooney, C. A. et al. Chondroitin sulfates play a major role in breast cancer metastasis: A role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res. 13, R58. https:\/\/doi.org\/10.1186\/bcr2895 (2011).","journal-title":"Breast Cancer Res."},{"key":"7025_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","volume":"11","author":"C Chen","year":"2018","unstructured":"Chen, C., Zhao, S., Karnad, A. & Freeman, J. W. The biology and role of CD44 in cancer progression: Therapeutic implications. J. Hematol. Oncol. 11, 64. https:\/\/doi.org\/10.1186\/s13045-018-0605-5 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"7025_CR48","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.3389\/fimmu.2017.01911","volume":"8","author":"KM Ilieva","year":"2017","unstructured":"Ilieva, K. M. et al. Chondroitin sulfate proteoglycan 4 and its potential as an antibody immunotherapy target across different tumor types. Front. Immunol. 8, 1911. https:\/\/doi.org\/10.3389\/fimmu.2017.01911 (2017).","journal-title":"Front. Immunol."},{"key":"7025_CR49","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1054-3589(05)53014-X","volume":"53","author":"Y Wegrowski","year":"2006","unstructured":"Wegrowski, Y. & Maquart, F. X. Chondroitin sulfate proteoglycans in tumor progression. Adv. Pharmacol. 53, 297\u2013321. https:\/\/doi.org\/10.1016\/S1054-3589(05)53014-X (2006).","journal-title":"Adv. Pharmacol."},{"key":"7025_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-1-4939-7231-9_22","volume":"1654","author":"M Pietrowska","year":"2017","unstructured":"Pietrowska, M. et al. Isolation of exosomes for the purpose of protein cargo analysis with the use of mass spectrometry. Methods Mol. Biol. 1654, 291\u2013307. https:\/\/doi.org\/10.1007\/978-1-4939-7231-9_22 (2017).","journal-title":"Methods Mol. Biol."},{"key":"7025_CR51","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1021\/acs.jproteome.7b00913","volume":"17","author":"S Moggridge","year":"2018","unstructured":"Moggridge, S., Sorensen, P. H., Morin, G. B. & Hughes, C. S. Extending the compatibility of the SP3 paramagnetic bead processing approach for proteomics. J. Proteome Res. 17, 1730\u20131740. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00913 (2018).","journal-title":"J. Proteome Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07025-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07025-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07025-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T18:28:49Z","timestamp":1669314529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07025-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7025"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-07025-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-705229\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"10 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MD, AS, and PHS are co-founders of, and shareholders in VAR2 Pharmaceuticals (\n                      \n                      ) and VarCT Diagnostics (\n                      \n                      ). NAN, RD, TG, and SC are partially employed in VAR2 Pharmaceuticals. VAR2 Pharmaceuticals and VarCT Diagnostics are biotechnology companies that specialize in therapeutic and diagnostic development of the VAR2CSA technology. Rest of the authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3075"}}